PharmaCielo Ltd.

PCLOF · OTC
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$9,141-$16,298-$14,516-$26,630
Dep. & Amort.$1,265$1,414$1,579$1,256
Deferred Tax$0$0$0$0
Stock-Based Comp.$1,042$1,536$2,209$6,820
Change in WC$794$2,217-$1,790-$7,576
Other Non-Cash$4,071$5,981$2,643$6,056
Operating Cash Flow-$1,969-$5,150-$9,875-$20,073
Investing Activities
PP&E Inv.$0-$15-$522-$1,138
Net Acquisitions$0$0$0-$1,296
Inv. Purchases$0$0-$204-$546
Inv. Sales/Matur.$0$179$0$777
Other Inv. Act.$41$228$167$546
Investing Cash Flow$41$392-$558-$1,657
Financing Activities
Debt Repay.$469$4,628$5,173$4,612
Stock Issued$0$0$83$13,549
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$1,550$0$123$47
Financing Cash Flow$2,019$4,628$5,296$18,209
Forex Effect-$5$19-$28$0
Net Chg. in Cash$86-$111-$5,165-$3,521
Supplemental Information
Beg. Cash$62$173$5,338$8,860
End Cash$148$62$173$5,338
Free Cash Flow-$1,969-$5,165-$10,397-$21,211